8,877
Total Claims
$1.0M
Drug Cost
879
Beneficiaries
$1,171
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-17%
Cost per patient vs peers
$1,171 vs $1,411 avg
+38%
Brand preference vs peers
14.7% vs 10.6% avg
Brand vs Generic
85% generic
Brand: 1,281 claims · $848K
Generic: 7,463 claims · $175K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 89 | $211K |
| Semaglutide | 49 | $93K |
| Empagliflozin | 48 | $68K |
| Denosumab | 27 | $45K |
| Apixaban | 42 | $36K |
| Rivaroxaban | 21 | $30K |
| Insulin Glargine,hum.Rec.Anlog | 37 | $26K |
| Tirzepatide | 14 | $21K |
| Dapagliflozin Propanediol | 13 | $21K |
| Insulin Lispro | 18 | $19K |
| Insulin Detemir | 19 | $15K |
| Levothyroxine Sodium | 861 | $15K |
| Atorvastatin Calcium | 907 | $12K |
| Estrogens, Conjugated | 21 | $9,543 |
| Budesonide/Formoterol Fumarate | 12 | $9,446 |
Prescribing Profile
Patient Profile
76
Avg Age
71%
Female
0.90
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About